Page last updated: 2024-08-17

levodopa and Akinetic Autism

levodopa has been researched along with Akinetic Autism in 13 studies

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19905 (38.46)18.7374
1990's1 (7.69)18.2507
2000's5 (38.46)29.6817
2010's2 (15.38)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Guery, D; Nighoghossian, N; Ong, E1
Lim, SY; Ng, RX; Tan, AH1
Shinohara, Y; Takahashi, H1
Onofrj, M; Thomas, A1
Jansson, R; Nyholm, D; Remahl, IN; Willows, T1
Ross, ED; Stewart, RM1
Berciano, J; Combarros, O; Infante, J1
Alexander, MP1
Minderhoud, JM; van Weerden, TW; van Woerkom, TC1
Bricolo, A1
Hyland, K; Surtees, R1
Kurahashi, K; Matsunaga, M; Narita, S; Tanaka, T; Watahiki, Y1
Patterson, JF1

Reviews

1 review(s) available for levodopa and Akinetic Autism

ArticleYear
[Diagnosis and therapy for patients with vascular parkinsonism].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2003, Aug-10, Volume: 92, Issue:8

    Topics: Akinetic Mutism; Amantadine; Antiparkinson Agents; Cerebral Infarction; Dementia, Vascular; Diagnosis, Differential; Gait Disorders, Neurologic; Humans; Levodopa; Muscle Rigidity; Parkinson Disease, Secondary; Platelet Aggregation Inhibitors; Posture; Secondary Prevention; Tremor

2003

Other Studies

12 other study(ies) available for levodopa and Akinetic Autism

ArticleYear
Akinetic mutism reversibility after L-dopa therapy in unilateral left anterior cerebral artery infarction.
    Neurocase, 2017, Volume: 23, Issue:2

    Topics: Akinetic Mutism; Dopamine Agents; Female; Humans; Infarction, Anterior Cerebral Artery; Levodopa; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Middle Aged

2017
Osmotic Demyelination Syndrome With Evolving Movement Disorders.
    JAMA neurology, 2018, 07-01, Volume: 75, Issue:7

    Topics: Acute Disease; Adult; Akinetic Mutism; Athetosis; Benserazide; Chorea; Demyelinating Diseases; Dopamine Agents; Drug Combinations; Fluid Therapy; Gastroenteritis; Humans; Hyponatremia; Levodopa; Male; Myelinolysis, Central Pontine; Parkinsonian Disorders; Saline Solution; Time Factors

2018
Acute akinesia in Parkinson disease.
    Neurology, 2005, Apr-12, Volume: 64, Issue:7

    Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Akinetic Mutism; Apomorphine; Body Temperature; Cohort Studies; Comorbidity; Dopamine Agents; Dose-Response Relationship, Drug; Drug Resistance; Female; Gastrointestinal Diseases; Humans; Levodopa; Male; Middle Aged; Mortality; Neuroleptic Malignant Syndrome; Parkinson Disease; Prospective Studies; Recovery of Function; Treatment Failure

2005
Long-term 24-hour duodenal infusion of levodopa: outcome and dose requirements.
    Neurology, 2005, Nov-08, Volume: 65, Issue:9

    Topics: Akinetic Mutism; Antiparkinson Agents; Chronobiology Disorders; Dopamine Agents; Dose-Response Relationship, Drug; Drug Administration Routes; Drug Administration Schedule; Drug Therapy, Combination; Drug Tolerance; Duodenum; Humans; Infusion Pumps; Levodopa; Male; Middle Aged; Parkinson Disease; Retrospective Studies; Sleep Wake Disorders; Time; Time Factors; Treatment Outcome

2005
Akinetic mutism from hypothalamic damage: successful treatment with dopamine agonists.
    Neurology, 1981, Volume: 31, Issue:11

    Topics: Adult; Akinetic Mutism; Bromocriptine; Carbidopa; Ergolines; Humans; Hypothalamic Neoplasms; Hypothalamus; Levodopa; Male; Methylphenidate; Postoperative Complications

1981
Akinetic mutism from frontal lobe damage responding to levodopa.
    Journal of neurology, 2000, Volume: 247, Issue:7

    Topics: Adult; Akinetic Mutism; Dopamine Agents; Female; Frontal Lobe; Humans; Levodopa; Treatment Outcome

2000
Chronic akinetic mutism after mesencephalic-diencephalic infarction: remediated with dopaminergic medications.
    Neurorehabilitation and neural repair, 2001, Volume: 15, Issue:2

    Topics: Adult; Akinetic Mutism; Carbidopa; Cerebral Infarction; Chronic Disease; Diencephalon; Dopamine Agents; Dopamine Agonists; Drug Therapy, Combination; Female; Humans; Levodopa; Magnetic Resonance Imaging; Mesencephalon; Neuropsychological Tests; Pergolide

2001
On the nature of brain stem disorders in severe head injured patients. II. A study on caloric vestibular reactions and neurotransmitter treatment.
    Acta neurochirurgica, 1976, Volume: 34, Issue:1-4

    Topics: Akinetic Mutism; Brain Injuries; Brain Stem; Caloric Tests; Child, Preschool; Coma; Consciousness; Humans; Levodopa; Middle Aged; Neurotransmitter Agents; Physostigmine; Time Factors; Vestibular Function Tests

1976
28. The medical therapy of the apallic syndrome.
    Monographien aus dem Gesamtgebiete der Psychiatrie, 1977, Volume: 14

    Topics: Akinetic Mutism; Amino Acids; Amphetamines; Anabolic Agents; Antidepressive Agents; Humans; Levodopa; Muscle Relaxants, Central; Psychotropic Drugs; Vasodilator Agents

1977
L-3,4-dihydroxyphenylalanine (levodopa) lowers central nervous system S-adenosylmethionine concentrations in humans.
    Journal of neurology, neurosurgery, and psychiatry, 1990, Volume: 53, Issue:7

    Topics: Adolescent; Akinetic Mutism; Biopterins; Child, Preschool; Humans; Infant; Levodopa; Methionine; NADH, NADPH Oxidoreductases; Phenylketonurias; Pyridoxine; S-Adenosylmethionine; Tetrahydrofolates; Tyrosine

1990
[Akinetic mutism from recurrent hydrocephalus: successful treatment with levodopa, bromocriptine and trihexyphenidyl].
    No to shinkei = Brain and nerve, 1987, Volume: 39, Issue:10

    Topics: Adult; Akinetic Mutism; Bromocriptine; Drug Therapy, Combination; Humans; Hydrocephalus; Levodopa; Male; Recurrence; Trihexyphenidyl

1987
Akinetic parkinsonism and the catatonic syndrome: an overview.
    Southern medical journal, 1986, Volume: 79, Issue:6

    Topics: Adult; Akinetic Mutism; Benztropine; Carbidopa; Catatonia; Humans; Levodopa; Male; Parasympatholytics; Parkinson Disease; Syndrome

1986